|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-1-61779-615-9 |
003 |
DE-He213 |
005 |
20220116161829.0 |
007 |
cr nn 008mamaa |
008 |
120403s2012 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781617796159
|9 978-1-61779-615-9
|
024 |
7 |
|
|a 10.1007/978-1-61779-615-9
|2 doi
|
050 |
|
4 |
|a RB1-214
|
072 |
|
7 |
|a MMF
|2 bicssc
|
072 |
|
7 |
|a MED067000
|2 bisacsh
|
072 |
|
7 |
|a MKF
|2 thema
|
082 |
0 |
4 |
|a 616.07
|2 23
|
245 |
1 |
0 |
|a Biotargets of Cancer in Current Clinical Practice
|h [electronic resource] /
|c edited by Mauro Bologna.
|
250 |
|
|
|a 1st ed. 2012.
|
264 |
|
1 |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2012.
|
300 |
|
|
|a XVI, 563 p. 100 illus., 57 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Current Clinical Pathology,
|x 2197-7828
|
505 |
0 |
|
|a Central Nervous System Tumors -- Head and Neck Tumors -- Thyroid Cancer -- Targeted Therapies for Non-Small Cell Lung Cancer -- Non-Hodgkin Lymphomas -- Leukemias -- Breast Cancer -- Esophago-Gastric Cancer -- Colorectal Cancer -- Hepatocellular Carcinoma -- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma -- Bladder Cancer -- Biomarkers in Prostate cancer -- Ovarian Cancer -- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer -- Biotargets in Sarcomas: The Past, Present and a Look into the Future -- Melanoma and other skin cancers -- Molecular pathology of cancer metastasis: suggestions for future therapy -- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools.
|
520 |
|
|
|a Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.
|
650 |
|
0 |
|a Pathology.
|
650 |
|
0 |
|a Oncology.
|
650 |
|
0 |
|a Medicine-Research.
|
650 |
|
0 |
|a Biology-Research.
|
650 |
1 |
4 |
|a Pathology.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Biomedical Research.
|
700 |
1 |
|
|a Bologna, Mauro.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781617796142
|
776 |
0 |
8 |
|i Printed edition:
|z 9781617796166
|
776 |
0 |
8 |
|i Printed edition:
|z 9781493959464
|
830 |
|
0 |
|a Current Clinical Pathology,
|x 2197-7828
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-1-61779-615-9
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|